
Bri-Chem Corp. is facing a tough day as its stock drops sharply in today's trading session.
Bri-Chem Corp. (BRY.TO) is down 6.25%, with its stock price falling to CA$0.30. This decline raises concerns among investors about the company's future performance in a challenging market.
Advertisement
Bri-Chem Corp.
BRY.TO
BRY.TO
Bri-Chem Corp.
Advertisement
Market cap
$8.46M
P/E
4.6x
52W high
$0.44
52W low
$0.20
1W change
-13.51%
Beta
-0.75
Analyst Price Targets
Based on analyst covering BRY
Wall Street analysts forecast BRY stock price to fall 31.3% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.22
-31.3% Upside
Current Price
C$0.32
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BRY's historical volatility
30-Day Vol
71.0%
Annualized
90-Day Vol
78.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.27
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.30 | C$0.24 – C$0.39 |
| 60 trading days | C$0.28 | C$0.20 – C$0.40 |
| 90 trading days | C$0.27 | C$0.18 – C$0.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious as Bri-Chem's stock struggles, indicating potential underlying issues that could impact its long-term viability.
Bri-Chem's stock down 6.25% today
With a market cap of about CA$8.46 million, Bri-Chem's stock performance is under scrutiny as it faces challenges in a competitive market.
Bull case
Despite today's drop, Bri-Chem has recently secured a supply agreement with Reliant Technologies. This partnership could strengthen its product lineup and support future growth.
Bear case
The sharp decline in stock price today highlights ongoing worries about Bri-Chem's financial performance, especially after a reported drop in sales and adjusted EBITDA in its last quarterly results.
Market Reaction
Advertisement
Bri-Chem's stock fell by 6.25% today, reflecting investor concerns over the company's recent performance. The stock closed at CA$0.30, a significant drop that may suggest deeper issues within the company.
Financial Health Concerns
The decline in Bri-Chem's stock follows disappointing financial results, showing a decrease in sales and adjusted EBITDA. Investors are likely concerned about the sustainability of the company's operations and its ability to compete in the market.
Looking Ahead
While Bri-Chem has secured a supply agreement with Reliant Technologies, the immediate market reaction suggests that investors are focusing on the company's current financial health rather than potential future benefits. Stakeholders should monitor upcoming financial disclosures and market trends to assess the company's recovery potential.
Advertisement
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.


